Double Blind, Double Dummy, Randomised, Multicentre, Four Arm Parallel Group Study to Assess the Efficacy and Safety of FlutiForm pMDI 250/10microg (2 Puffs Bid) vs Fluticasone pMDI 250microg (2 Puffs Bid) Plus Formoterol pMDI 12microg (2 Puffs Bid) Administered Concurrently in Adult Subjects With Severe Persistent, Reversible Asthma.
Phase of Trial: Phase III
Latest Information Update: 05 Mar 2018
At a glance
- Drugs Fluticasone propionate; Formoterol; Formoterol/fluticasone propionate
- Indications Asthma
- Focus Therapeutic Use
- 31 Dec 2010 Results published in Respiratory Medicine.
- 22 Sep 2010 Results presented at the 20th Annual Congress of the European Respiratory Society.
- 22 Sep 2010 Results for comparison between formoterol/fluticasone propionate and formoterol + fluticasone propionate were presented at the 20th Annual Congress of the European Respiratory Society.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History